By John McKeown ( December 22, 2025, 12:02 PM EST) -- In Novartis AG v. Biogen Inc., 2024 FC 52, the plaintiff successfully sued for infringement of its registered trademark and passing off for a pharmaceutical preparation for ophthalmology and pharmaceutical preparations for prevention and treatment of ocular disorders and diseases....